title: Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?
authors.forename: G K
authors.initials: GK
authors.lastname: Isbister
authors.forename: A
authors.initials: A
authors.lastname: Dawson
authors.forename: I M
authors.initials: IM
authors.lastname: Whyte
authors.forename: F H
authors.initials: FH
authors.lastname: Prior
authors.forename: C
authors.initials: C
authors.lastname: Clancy
authors.forename: A J
authors.initials: AJ
authors.lastname: Smith
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D009357:Neonatal Abstinence Syndrome / Q000175:diagnosis*; D017374:Paroxetine / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D009626:Terminology as Topic
chemical_list: D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors